INVESTOR AB

PrivateCIK: 889232
📋 What this filing means

INVESTOR AB filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $14.40B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

7
Positions
$14.40B
Total AUM (reported)
110.99M
Total Shares

Allocation by class

TOTAL AUM$14.40B7 positions
ORD$9.78B67.9%
COM$4.61B32.0%
SHS NEW$12.82M0.1%
ORDINARY SHARES$1.09M0.0%

Portfolio Concentration

Top 3100.0%4–100.0%TOP 10100.0%0%100%
Top 3$14.40B100.0%
4–10$2.33M0.0%

Top 3 weight

100.0%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 110.99M

Sole

Full voting authority

110.99M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole7
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings7
Rows:

ASTRAZENECA PLC

SOLE
ORD
Shares51.59M
TypeSH
Market value$9.78B
67.92%
Sole
51.59M
Shared
0.00
None
0.00

NASDAQ INC

SOLE
COM
Shares58.44M
TypeSH
Market value$4.61B
31.98%
Sole
58.44M
Shared
0.00
None
0.00

MEDIWOUND LTD

SOLE
SHS NEW
Shares872.09K
TypeSH
Market value$12.82M
0.09%
Sole
872.09K
Shared
0.00
None
0.00

CELLEBRITE DI LTD

SOLE
ORDINARY SHARES
Shares75K
TypeSH
Market value$1.09M
<0.01%
Sole
75K
Shared
0.00
None
0.00

MICRON TECHNOLOGY INC

SOLE
COM
Shares470.00
TypeSH
Market value$542.5K
<0.01%
Sole
470.00
Shared
0.00
None
0.00

VERIZON COMMUNICATIONS INC

SOLE
COM
Shares11.30K
TypeSH
Market value$478.4K
<0.01%
Sole
11.30K
Shared
0.00
None
0.00

BIOMARIN PHARMACEUTICAL INC

SOLE
COM
Shares3.70K
TypeSH
Market value$211.7K
<0.01%
Sole
3.70K
Shared
0.00
None
0.00